Fourthly, our finding that CD26high/CD26low CD8+ T cells are polyfunctional and exhibit greater migratory capacity, stemness, longevity, and proliferation capability make them a potential candidate for adoptive T cell transfer or CAR T cell therapy in CLL. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.